pageInfo({
    time : "1261212700621"
  
	    , page : null
	  
	    , url : null
	  
	    , instrument : null
	  
	    , article : {
	        storyId : "UKDKT00257820090707"
	        , headline : "Lundbeck sees $250 mln Xenazine sales in 2012-15"
	        , keywords : "[Pharmaceuticals - generic and speciality, Pharmaceuticals (sub-industry), Denmark, Nordic Countries, Europe, United States of America, Healthcare, Pharmaceuticals and biotechnology, Western Europe, Industrial machinery, Machinery, Pharmaceuticals - diversified, United Kingdom, Mergers and Acquisitions (including Changes of Ownership), Corporate Results Forecasts, Bosnia and Herzegovina, Eastern Europe, Economic news, EC, business/financial pages]"
	        , tickers : "[de;LDB, de;LDBF, de;LDBS, de;LDBX, dk;LUN, us;HLUK, LUN.CO]"
	    }
	    , channel : {
	        id : "54"
	        , name : "companyNews"
	        , title : "Company News"
	    }})